Breaking News Instant updates and real-time market news.

WSM

Williams-Sonoma

$51.51

0.44 (0.86%)

, LZB

La-Z-Boy

$29.20

0.09 (0.31%)

11:31
01/24/19
01/24
11:31
01/24/19
11:31

RH rises as Citron Research sees suitors lining up to buy 'rare trophy asset'

Shares of RH (RH) are on the rise on Thursday morning after Citron Research called it "the most compelling story in retail," and said it sees suitors lining up to buy "this rare trophy asset with 0 competition." Citron set a $250 price target on the stock. 'MOST COMPELLING STORY' IN RETAIL: Andrew Left's Citron Research said in a newly published report that RH has created "the most exciting concept in retail since the creation of the Apple [AAPL] store," and has become a company with no peer, with "no competition domestic or international." Setting a $250 price target on the stock, Citron argued that RH has become the only significant anchor tenant for shopping districts amid the decline of physical retail, which allowed it to secure new galleries at a rent per square foot that is about 50% lower than their prior mall-based stores. "What RH has built in North America over the past six years is nothing short of breathtaking. But, what is most exciting is the future of RH internationally," the report noted. Moreover, Citron pointed out that the stock is currently being valued on par with Ethan Allen (ETH), La-Z-Boy (LZB), and Williams Sonoma (WSM). "Once Wall Street wakes up and realizes that RH is to furniture what Whole Foods [AMZN] is to groceries, the multiple will readjust higher," the report contended. Citron does not believe RH will stay public for much longer as the value of the company "is clear" and the firm expects an offer to be made that the company will not be able to refuse. "As large shareholders, we would be disappointed if RH sold for anything less than $250 a share. This would still make it less expensive than Wayfair [W]," the report added. PRICE ACTION: In late morning trading, shares of RH have gained almost 4% to $135.50.

WSM

Williams-Sonoma

$51.51

0.44 (0.86%)

LZB

La-Z-Boy

$29.20

0.09 (0.31%)

ETH

Ethan Allen

$18.49

0.07 (0.38%)

AAPL

Apple

$152.08

-1.83 (-1.19%)

RH

RH

$135.12

4.56 (3.49%)

AMZN

Amazon.com

$1,632.99

-8.51 (-0.52%)

W

Wayfair

$98.50

2.53 (2.64%)

  • 28

    Jan

  • 28

    Jan

  • 29

    Jan

  • 31

    Jan

  • 04

    Feb

  • 20

    Feb

  • 22

    Feb

  • 03

    Mar

WSM Williams-Sonoma
$51.51

0.44 (0.86%)

01/23/19
01/23/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Underperform from Sector Perform at RBC Capital with analyst Joseph Spak saying the company's more "tactful messaging" conveys downward pressure to growth expectations and also sees the "realities" of Tesla becoming a volume player highlighting its "challenges to scale and deliver high volume at high ASPs/margins." 2. Lowe's (LOW) downgraded to Hold from Buy at Loop Capital with analyst Laura Champine saying she thinks she was previously too optimistic on Lowe's likely margin progression. 3. Williams-Sonoma (WSM) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman saying he believes top and bottom-line pressures will intensify in 2019. 4. Merck (MRK) downgraded to Market Perform from Outperform at BMO Capital with analyst Alex Arfaei citing the company's over-dependence on Keytruda, the Street's high expectations, and his views on upcoming competitor trials combining for a more balanced risk-reward on Merck. 5. Pfizer (PFE) and Mylan (MYL) were downgraded to Neutral from Buy at UBS. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/23/19
01/23/19
DOWNGRADE
Target $49

Underweight
Morgan Stanley downgrades Williams-Sonoma to Underweight on intensified pressure
As previously reported, Morgan Stanley analyst Simeon Gutman downgraded Williams-Sonoma to Underweight from Equal Weight as he believes top and bottom-line pressures will intensify in 2019. He projects same-store sales growth may slow more than the market is expecting in 2019 due to moderating Pottery Barn sales, a slowdown in consumer spending and competition "reaching new heights in home furnishings." Additionally, Williams-Sonoma is more exposed to tariffs than most retailers he covers, Gutman noted. He cut his price target on Williams-Sonoma shares to $49 from $55.
01/23/19
MSCO
01/23/19
DOWNGRADE
MSCO
Underweight
Williams-Sonoma downgraded to Underweight from Equal Weight at Morgan Stanley
11/16/18
FBCO
11/16/18
NO CHANGE
Target $50
FBCO
Underperform
Williams-Sonoma price target cut to $50 from $55 at Credit Suisse
Credit Suisse analyst Seth Sigman maintained an Underperform rating on Williams-Sonoma and lowered his price target to $50 after the company reported weaker Q3 results with comps and EBIT below estimates. Looking to Q4, Sigman says the company's sales guidance range is "very wide," and says relatively low inventory levels combined with a greater focus on reducing promotions and maintaining margins could ultimately weigh on growth during what should be a very competitive Q4.
LZB La-Z-Boy
$29.20

0.09 (0.31%)

12/17/18
SIDC
12/17/18
UPGRADE
Target $34
SIDC
Buy
La-Z-Boy upgraded to Buy from Neutral at Sidoti
Sidoti analyst Anthony Lebiedzinski upgraded La-Z-Boy to Buy from Neutral following a 34% decline in the shares since August. He believes the company is well-positioned to deal with tariffs compared to most peers and sees it product mix skewed to upholstery helping it continue to profitably increase revenue. Lebiedzinski keeps a $34 price target on La-Z-Boy shares.
08/23/18
08/23/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Duluth Holdings (DLTH) downgraded to Neutral from Outperform at Baird. 2. La-Z-Boy (LZB) downgraded to Sector Weight from Overweight at KeyBanc with analyst Bradley Thomas citing valuation. 3. PermRock Royalty Trust (PRT) downgraded to Hold from Buy at Stifel with analyst Timothy Howard saying he believes significant long-term value remains in the trust, but cites "elevated" capital spending in the near term and "Permian differential uncertainty" for the downgrade. 4. ABM (ABM) downgraded to Neutral from Outperform at Baird with analyst Andrew Wittmann saying he sees the risk/reward as more balanced given near-term uncertainties and a possible risk to near-term guidance. 5. Coca-Cola Amatil (CCLAY) downgraded to Sell from Neutral at UBS and to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/23/18
08/23/18
DOWNGRADE

Sector Weight
La-Z-Boy downgraded to Sector Weight on valuation at KeyBanc
As previously reported, KeyBanc analyst Bradley Thomas downgraded La-Z-Boy to Sector Weight from Overweight on valuation. With the stock 20%-plus year over year and valuation elevated, the analyst believes the risk/reward for shares is more balanced on a six-month time frame. Thomas sees organic sales moderating from Q1, and incremental margin pressure in the quarters ahead. Lastly, while difficult to quantify, China tariffs could lead to downside to his current EPS estimates if exemptions are not made for the industry.
08/23/18
KEYB
08/23/18
DOWNGRADE
KEYB
Sector Weight
La-Z-Boy downgraded to Sector Weight from Overweight at KeyBanc
ETH Ethan Allen
$18.49

0.07 (0.38%)

10/26/18
RAJA
10/26/18
DOWNGRADE
RAJA
Outperform
Ethan Allen downgraded to Outperform from Strong Buy at Raymond James
AAPL Apple
$152.08

-1.83 (-1.19%)

01/23/19
DADA
01/23/19
NO CHANGE
Target $245
DADA
Buy
Apple price target lowered to $245 from $260 at DA Davidson
DA Davidson analyst Tom Forte lowered his price target on Apple to $245 ahead of its Q1 earnings next week, saying the reduction reflects an update to his discounted cash flow model analysis with lower near-term outlook iPhone unit sales. The analyst is concerned that the sentiment from the company's suppliers also suggests that iPhone softness could last beyond the December quarter. Longer term, Forte keeps his Buy rating on Apple based on its "attractive" valuation at current levels, with potential near term catalysts coming from "better-than-expected results from its newer products Apple Watch and HomePod as well as an accelerated repurchase effort and increase in dividends."
01/23/19
OTRG
01/23/19
NO CHANGE
OTRG
Expectations for Apple iPhone Q1 order share down significantly, says OTR Global
OTR Global said its checks with hardware buyers and product managers at wireless carriers, wholesalers, and electronics retailers in Asia and Europe indicate that Apple's iPhone lost share in Europe, China and India during Q4 and that expectations for iPhone order share during Q1 are significantly lower.
01/24/19
BARD
01/24/19
NO CHANGE
Target $185
BARD
Outperform
Apple consensus estimates may still be too high, says Baird
Baird analyst William Power is cautious heading into Q2 results for Apple as he believes consensus estimates may still be too high given the challenging conditions in China and elsewhere. He said the Street is assuming a normal seasonal decline, but he believes it is a lot worse. He remains positive long-term, but he would be more cautious near-term until estimates are more fully reset. Power has an Outperform rating and $185 price target on Apple shares.
01/18/19
ADAM
01/18/19
NO CHANGE
Target $190
ADAM
Buy
Apple March quarter guidance expected to be soft, says Canaccord
Canaccord analyst T. Michael Walkley updated his model on Apple ahead of its earnings on January 29. The analyst's model reclassified revenues for the amortization of the deferred value of maps, Siri and free iCloud services from the bundled price of iPhone, Macs, and other products to services. He said despite his expectation for slower near-term iPhone sales, he anticipates the company to continue to grow its installed base and believes the company's ecosystem will contribute to ongoing growth. Walkley reiterated his Buy rating and $190 price target on Apple shares.
RH RH
$135.12

4.56 (3.49%)

12/04/18
KEYB
12/04/18
NO CHANGE
Target $180
KEYB
Overweight
RH price target raised to $180 from $166 at KeyBanc
KeyBanc analyst Bradley Thomas raised his price target for RH to $180 from $166, citing "strong" Q3 results. The analyst continues to see margins driving EPS upside and remains very positive on the long-term growth story ahead. He reiterates an Overweight rating on the shares.
01/07/19
KEYB
01/07/19
DOWNGRADE
KEYB
Sector Weight
RH downgraded to Sector Weight at KeyBanc
As previously reported, KeyBanc analyst Bradley Thomas downgraded RH to Sector Weight from Overweight as he believes Hardlines investors need to be increasingly selective in 2019. The analyst remains most negative on Home Furnishings from a competitive and cyclical perspective.
01/07/19
KEYB
01/07/19
DOWNGRADE
KEYB
Sector Weight
RH downgraded to Sector Weight from Overweight at KeyBanc
12/04/18
STFL
12/04/18
NO CHANGE
Target $180
STFL
Buy
RH price target raised to $180 from $150 at Stifel
Stifel analyst John Baugh noted that RH's Q3 results, as well as its 2018 and 2019 guidance, were above consensus, stating that he continues to be impressed with the company's ability to distinguish itself in the highly competitive retail industry. Given that investors have been increasingly bearish on the furnishings space, Baugh said he thinks RH's results will be well received. He maintains a Buy rating on RH shares and raised his price target on the stock to $180 from $150 based on his increase FY19 EPS estimate of $9.99.
AMZN Amazon.com
$1,632.99

-8.51 (-0.52%)

01/24/19
JEFF
01/24/19
NO CHANGE
JEFF
Jefferies finds nine more Rx licenses for PillPack facility in Arizona
Jefferies analyst Brian Tanquilut says his monthly checks with state boards of pharmacy reveal that PillPack's Arizona facility has been granted nine additional prescription licenses. The analyst expects Amazon (AMZN) will continue to pursue Rx licenses for PillPack's Arizona pharmacy in all the remaining states over the next six months. However, the company will still have to acquire or build a few more mail pharmacies and grow capacity before being able to go live with a consumer pharmacy offering, Tanquilut tells investors in a research note. Further, his monthly webscrape of Amazon's healthcare-related private label products indicates that the company's Solimo offering's growth accelerated significantly month-over-month in January. On private label over-the-counter drugs, Walgreens Boots Alliance (WBA) remains more expensive than Amazon's Basic Care offering, while CVS Health's (CVS) net prices are slightly more competitive due to higher discounting, Tanquilut says.
01/23/19
BARD
01/23/19
NO CHANGE
Target $2100
BARD
Amazon Q4 results should be in-line, guidance could be 'noisy,' says Baird
Baird analyst Colin Sebastian said holiday e-commerce trends suggest an in-line Q4 for Amazon, which translates into revenue being at the high end of guidance. However, the analyst believes Q1 guidance could be "noisy". He said recent changes to third-party marketplace/FBA fees, India regulations, and macro softness in the UK could muddy the near-term revenue and margin guidance, which keeps him below consensus for Q1. Sebastian reiterated his Outperform rating and $2,100 price target on Amazon.com shares.
01/22/19
RHCO
01/22/19
NO CHANGE
Target $2250
RHCO
Buy
Amazon.com remains 'compelling' on private label dominance, says SunTrust
SunTrust analyst Youssef Squali kept his Buy rating and $2,250 price target on Amazon.com but raised his outlook for revenue in FY22 to $31B from $25B, noting that he sees the company's private label sales growing strongly with estimated 40% increase this year. The analyst states that Amazon's "rise of private labels and exclusives is one of the least understood / most under-appreciated trends" for the company, and that the competitive advantage derived from it is hard to dislodge. Squali adds that the strategy also strengthens Amazon's "flywheel effect" of proprietary offerings, creates better user experience, and should support its margins over time.
01/17/19
RBCM
01/17/19
NO CHANGE
Target $20
RBCM
United Natural Foods price target lowered to $20 from $24 at RBC Capital
RBC Capital analyst William Kirk lowered his price target on United Natural Foods (UNFI) to $20 and kept his Sector Perform rating after its ICR conference presentation. The analyst notes that while the discussions supported his view of "favorable macro trends" in terms of freight, gas, and inflation costs, he is concerned with the risk around the company's "out-year synergies" around the integration of its Supervalu acquisition. Kirk further warns that Amazon (AMZN) Whole Foods combination has the "ability, incentive, and precedent history to de-emphasize" United Natural Foods business.
W Wayfair
$98.50

2.53 (2.64%)

12/07/18
SBSH
12/07/18
NO CHANGE
Target $117
SBSH
Neutral
Wayfair coverage transferred with Neutral at Citi
Citi transferred coverage of Wayfair to Nicholas Jones from Mark May. Jones has a Neutral rating on Wayfair shares with a $117 price target.
12/07/18
COWN
12/07/18
NO CHANGE
Target $130
COWN
Outperform
Wayfair price target raised to $130 from $120 at Cowen
Cowen analyst John Blackledge raised his price target on Wayfair to $130 from $120 following meetings with management. He noted management was positive on long-term opportunities and overall business trends appear strong. Blackledge reiterated his Outperform rating on Wayfair shares.
12/20/18
BARD
12/20/18
NO CHANGE
Target $2100
BARD
Outperform
Amazon fee changes should improve selection, volume, says Baird
After Amazon (AMZN) announced changes to marketplace referral fees, or take rates, as well as fulfillment and storage fees for fulfillment by Amazon, which will take effect in mid-February, Baird analyst Colin Sebastian says he thinks the fee changes should improve production selection and volume while offsetting higher delivery costs. Sebastian tells investors in a research note that he believes the Amazon Marketplace could be more competitive with traditional retailers such as Walmart (WMT) and Target (TGT), which currently sell significant volumes of consumables, and with online vertical sites such as Wayfair (W) in the Furniture/Home Decor category. He maintains an Outperform rating and $2,100 price target on Amazon shares.
11/28/18
BARD
11/28/18
NO CHANGE
Target $108
BARD
Neutral
Wayfair's 'impressive' Cyber Five results suggest upside potential, says Baird
After Wayfair reported that its direct retail sales increased 58% year-over-year for the five-day period between Thanksgiving and Cyber Monday, Baird analyst Colin Sebastian called the results "impressive" and noted that this represents an acceleration from 53% in 2017 and 52% in 2016. Noting that reported Q4 direct retail growth rates have averaged 80-85% of the "Cyber Five" growth rate over the last two years, Sebastian said the Cyber Five results suggest there is "considerable upside potential" for the quarter. However, he also believes the highly promotional nature of the holiday may be concentrating spending early in the holiday period and maintains a Neutral rating on Wayfair shares with a $108 price target.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

, GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

19:35
03/24/19
03/24
19:35
03/24/19
19:35
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

NFLX

Netflix

$361.00

-17.09 (-4.52%)

AMZN

Amazon.com

$1,764.96

-53.49 (-2.94%)

AMD

AMD

$26.43

-1.47 (-5.27%)

SNE

Sony

$42.09

-1.915 (-4.35%)

GME

GameStop

$10.57

0.03 (0.28%)

MSFT

Microsoft

$117.05

-3.6 (-2.98%)

CMCSA

Comcast

$39.56

-0.49 (-1.22%)

CMCSK

Comcast

$0.00

(0.00%)

SABR

Sabre

$21.02

-0.62 (-2.87%)

MAN

Manpower

$80.83

-5.02 (-5.85%)

WBS

Webster Financial

$48.90

-3.03 (-5.83%)

NATI

National Instruments

$44.16

-1.28 (-2.82%)

JCOM

j2 Global

$84.63

-1.95 (-2.25%)

IIPR

Innovative Industrial Properties

$90.00

-0.175 (-0.19%)

CAT

Caterpillar

$129.80

-4.1 (-3.06%)

LYFT

Lyft

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 25

    Mar

  • 26

    Mar

  • 26

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 02

    Apr

  • 04

    Apr

  • 16

    Apr

  • 18

    Apr

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 29

    Apr

  • 29

    Apr

  • 10

    May

  • 12

    Jun

  • 27

    Oct

  • 29

    Mar

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

, GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

19:26
03/24/19
03/24
19:26
03/24/19
19:26
Periodicals
YouTube cancels plans for high-end dramas, comedies, Bloomberg reports »

Google-owned (GOOG;…

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

NFLX

Netflix

$361.00

-17.09 (-4.52%)

AMZN

Amazon.com

$1,764.96

-53.49 (-2.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

  • 29

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

ENTG

Entegris

$34.64

-1.2 (-3.35%)

19:23
03/24/19
03/24
19:23
03/24/19
19:23
Hot Stocks
Taiwan court finds Gudeng Precision infringes Entegris' reticle pod patent »

Entegris received an oral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

MGTA

Magenta Therapeutics

$18.77

0.805 (4.48%)

19:21
03/24/19
03/24
19:21
03/24/19
19:21
Downgrade
Magenta Therapeutics rating change at Goldman Sachs »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$31.03

-0.05 (-0.16%)

, CMCSA

Comcast

$39.56

-0.49 (-1.22%)

16:20
03/24/19
03/24
16:20
03/24/19
16:20
Hot Stocks
Box Office Battle: 'Us' soars to historic $70M U.S. debut »

Comcast (CMCSA, CMCSK)…

T

AT&T

$31.03

-0.05 (-0.16%)

CMCSA

Comcast

$39.56

-0.49 (-1.22%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$42.09

-1.915 (-4.35%)

LGF.A

Lionsgate

$15.14

-0.7 (-4.42%)

DIS

Disney

$108.30

-0.36 (-0.33%)

VIAB

Viacom

$25.27

-0.7 (-2.70%)

VIA

Viacom

$30.64

-0.66 (-2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

  • 24

    Apr

  • 25

    Apr

  • 26

    Apr

  • 07

    May

  • 08

    May

  • 20

    May

  • 06

    Jun

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

, SPX

S&P 500

$0.00

(0.00%)

16:07
03/24/19
03/24
16:07
03/24/19
16:07
Periodicals
Not enough evidence Trump obstructed justice, conspired with Russia, CNBC says »

Attorney General William…

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

, SPX

S&P 500

$0.00

(0.00%)

15:58
03/24/19
03/24
15:58
03/24/19
15:58
Periodicals
Mueller finds no Trump campaign-Russia conspiracy, Reuters reports »

Special Counsel Robert…

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASND

Ascendis Pharma

$119.21

-3.85 (-3.13%)

15:35
03/24/19
03/24
15:35
03/24/19
15:35
Hot Stocks
Ascendis Pharma announces top-line results from Phase 3 heiGHt trial »

Ascendis Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

, SPX

S&P 500

$0.00

(0.00%)

12:50
03/24/19
03/24
12:50
03/24/19
12:50
Periodicals
Trump, lawmakers awaiting details of Mueller's report, Reuters says »

U.S. lawmakers drew…

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

, SPX

S&P 500

$0.00

(0.00%)

12:44
03/24/19
03/24
12:44
03/24/19
12:44
Periodicals
China refusing to concede on U.S. demands to ease curb on tech companies,FT says »

China is refusing to…

SPY

SPDR S&P 500 ETF Trust

$279.55

-5.08 (-1.78%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$175.60

-5.785 (-3.19%)

12:37
03/24/19
03/24
12:37
03/24/19
12:37
Periodicals
Alibaba acquires Israeli AR startup, Bloomberg reports »

Alibaba has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

12:34
03/24/19
03/24
12:34
03/24/19
12:34
Periodicals
Bayer CEO says team retains backing if supervisory board, Reuters says »

Bayer's management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

AAL

American Airlines

$30.60

-0.83 (-2.64%)

, BA

Boeing

$362.15

-10.54 (-2.83%)

12:31
03/24/19
03/24
12:31
03/24/19
12:31
Periodicals
American Airlines extends Boeing 737 Max flight cancellations, Reuters says »

American Airlines (AAL)…

AAL

American Airlines

$30.60

-0.83 (-2.64%)

BA

Boeing

$362.15

-10.54 (-2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

UBER

Uber

$0.00

(0.00%)

12:27
03/24/19
03/24
12:27
03/24/19
12:27
Periodicals
Uber to announce $3.1B deal to buy Careem, Bloomberg says »

Uber is set to announce a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDUS

Radius Health

$18.92

-0.39 (-2.02%)

12:17
03/24/19
03/24
12:17
03/24/19
12:17
Hot Stocks
Radius presents analysis from Phase 3 ACTIVE trial, data from TYMLOS studies »

Radius Health presented a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIPR

Innovative Industrial Properties

$90.00

-0.175 (-0.19%)

13:09
03/23/19
03/23
13:09
03/23/19
13:09
Periodicals
Innovative Industrial Properties flying high, Barron's says »

American cannabis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$129.80

-4.1 (-3.06%)

13:05
03/23/19
03/23
13:05
03/23/19
13:05
Periodicals
Investors missing how far Caterpillar dug into costs, Barron's says »

Caterpillar has made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

MO

Altria Group

$55.90

-0.23 (-0.41%)

12:59
03/23/19
03/23
12:59
03/23/19
12:59
Periodicals
E-cigarettes not helping people quit smoking, Barron's says »

According to the CDC,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

MAN

Manpower

$80.83

-5.02 (-5.85%)

, SABR

Sabre

$21.02

-0.62 (-2.87%)

12:51
03/23/19
03/23
12:51
03/23/19
12:51
Periodicals
Sabre, j2 Global among mid-cap stocks with sustainable dividends, Barron's says »

When it comes to…

MAN

Manpower

$80.83

-5.02 (-5.85%)

SABR

Sabre

$21.02

-0.62 (-2.87%)

WBS

Webster Financial

$48.90

-3.03 (-5.83%)

NATI

National Instruments

$44.16

-1.28 (-2.82%)

JCOM

j2 Global

$84.63

-1.95 (-2.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    Apr

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 10

    May

MSFT

Microsoft

$117.05

-3.6 (-2.98%)

, GME

GameStop

$10.57

0.03 (0.28%)

12:47
03/23/19
03/23
12:47
03/23/19
12:47
Periodicals
Gaming meets the cloud as investors scramble to catch up, Barron's says »

The cloud will eventually…

MSFT

Microsoft

$117.05

-3.6 (-2.98%)

GME

GameStop

$10.57

0.03 (0.28%)

AMD

AMD

$26.43

-1.47 (-5.27%)

SNE

Sony

$42.09

-1.915 (-4.35%)

GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 29

    Mar

  • 02

    Apr

  • 04

    Apr

  • 16

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

LYFT

Lyft

$0.00

(0.00%)

12:42
03/23/19
03/23
12:42
03/23/19
12:42
Periodicals
Investors should avoid booking ride when Lyft goes public, Barron's says »

Lyft will soon be going…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

DIS

Disney

$108.30

-0.36 (-0.33%)

, AAPL

Apple

$191.11

-3.96 (-2.03%)

12:38
03/23/19
03/23
12:38
03/23/19
12:38
Periodicals
Streaming revolution too complicated, Barron's says »

The streaming revolution…

DIS

Disney

$108.30

-0.36 (-0.33%)

AAPL

Apple

$191.11

-3.96 (-2.03%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$39.56

-0.49 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 11

    Apr

  • 25

    Apr

  • 08

    May

FB

Facebook

$164.25

-1.83 (-1.10%)

, GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

08:18
03/23/19
03/23
08:18
03/23/19
08:18
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

FB

Facebook

$164.25

-1.83 (-1.10%)

GOOG

Alphabet

$1,204.85

-26.86 (-2.18%)

GOOGL

Alphabet Class A

$1,206.00

-30.38 (-2.46%)

TWTR

Twitter

$32.98

0.37 (1.13%)

GM

General Motors

$36.51

-0.84 (-2.25%)

AMD

AMD

$26.43

-1.47 (-5.27%)

INTC

Intel

$53.20

-1.41 (-2.58%)

MRVL

Marvell

$19.69

-1.11 (-5.34%)

MCHP

Microchip

$85.50

-1.83 (-2.10%)

MU

Micron

$41.68

-2.32 (-5.27%)

NVDA

Nvidia

$177.40

-6.52 (-3.55%)

QCOM

Qualcomm

$56.71

-1.05 (-1.82%)

TXN

Texas Instruments

$109.51

-2.68 (-2.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 27

    Mar

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

  • 23

    Apr

  • 25

    Apr

  • 25

    Apr

  • 29

    Apr

  • 29

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

  • 04

    Jun

  • 05

    Jun

  • 27

    Oct

21:30
03/22/19
03/22
21:30
03/22/19
21:30
General news
Breaking General news story  »

Chicago Federal Reserve…

21:15
03/22/19
03/22
21:15
03/22/19
21:15
General news
Breaking General news story  »

Atlanta Federal Reserve…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.